Kyle Murray

Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide μ (mu) and plasmid DNA

Takanobu Tagawa, Michelle C Manvell, Neal Brown et al. · Gene Therapy · 2002 · 78 citations

Dna Nanotechnology, Protein Nanoparticles, Cationic Liposomes +5

Enhanced cationic liposome-mediated transfection using the DNA-binding peptide μ (mu) from the adenovirus core

Kyle Murray, Christopher J. Etheridge, Syed Imran Ali Shah et al. · Gene Therapy · 2001 · 70 citations · Full text

Natural Sciences, Adenovirus Core, Dna-binding Peptide μ +7

Leveraging intrinsic flexibility to engineer enhanced enzyme catalytic activity

Christos S. Karamitros, Kyle Murray, Brent Winemiller et al. · Proceedings of the National Academy of Sciences · 2022 · 45 citations · Full text

Engineering, Molecular Biology, Chemical Biology +22

Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme

John Blazeck, Christos S. Karamitros, Kyle Ford et al. · Nature Catalysis · 2022 · 20 citations · Full text

Human Immunotherapeutic Enzyme, Engineering, Protein Expression +14

Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon

Kyle Murray, Andrew McQuillin, Luisa Stewart et al. · Gene Therapy · 1999 · 18 citations

Chromatin, Human Cell, Ventral Mesencephalon +10